Oxaliplatin Workflows for Cancer Research
2026-08-20
Build reproducible Oxaliplatin assays for cytotoxicity, DNA damage, apoptosis, and chemotherapy-resistance studies. The workflow combines practical dosing guidance with an ABCB1-focused strategy inspired by recent colorectal cancer research.
Cy3 TSA Fluorescence System Kit for Cardiac Research
2026-08-19
Map low-abundance inflammatory and endothelial signals in doxorubicin-injured heart models with localized Cy3 tyramide amplification. This workflow combines sensitive tissue imaging, practical optimization controls, and mechanistic guidance from recent STING/NLRP3 research.
Cy3 TSA Fluorescence System Kit for Sensitive IHC
2026-08-19
Turn weak protein and nucleic-acid signals into microscopy-ready data with a practical Cy3 TSA Fluorescence System Kit workflow. This guide connects tyramide amplification to liver-cancer metabolism research, with assay design, optimization ranges, controls, and troubleshooting for IHC, ICC, and ISH.
Trilaurin: From Lipid Excipient to Translational Platform
2026-08-18
Trilaurin, also known as Glycerol Tridodecanoate, is more than a formulation lipid: its C12 triacylglycerol structure supports biocatalytic synthesis, oral peptide and protein delivery, and translationally relevant nanomedicine research.
Go 6983 in WDR36–Glycolysis Research
2026-08-18
Go 6983 is a pan-PKC inhibitor that can help test whether PKC-dependent signaling contributes to WDR36-associated glycolytic and trophectoderm phenotypes. This article translates a human blastoid study into a rigorous, hypothesis-driven assay strategy while separating established evidence from exploratory applications.
Perphenazine Research Workflows and Applications
2026-08-17
Perphenazine combines potent dopamine D2 receptor antagonism with a broad phenothiazine receptor profile, making it useful for neuronal, mitochondrial, behavioral, and host-directed antibacterial studies. This guide translates its published activity into practical assay designs, control strategies, and troubleshooting decisions for reproducible research.
Cy3 TSA Fluorescence System Kit for Spatial Biology
2026-08-17
The Cy3 TSA Fluorescence System Kit enables sensitive spatial analysis of NET-DNA, ILC3s, and epithelial repair. This article connects TSA assay design with mechanistic evidence from ulcerative colitis research, emphasizing controls, localization, and interpretation.
BMX-IN-1: Selective BMX Kinase Inhibitor Guide
2026-08-16
BMX-IN-1 is an irreversible BMX kinase inhibitor for studying Tec-family signaling, cancer biology, angiogenesis, and host–pathogen mechanisms. Product data report covalent BMX binding, cellular activity at concentrations as low as 300 nM after 24 hours, G0/G1 arrest, and apoptosis induction in cancer cells.
Deuterium-Labeled Degarelix: Synthesis and Significance
2026-08-15
The reference study presents a practical route to deuterium-labeled degarelix acetate by introducing a d7-naphthyl amino acid building block with D2O/D3PO4 before peptide assembly. Its main contribution is methodological: it combines early isotope incorporation with Fmoc-based solid-phase synthesis to provide an internal standard for future degarelix ADME studies.
Meropenem Trihydrate in Resistance Phenotyping
2026-08-14
Meropenem trihydrate is more than a broad-spectrum carbapenem antibiotic: it can serve as a defined perturbation tool within resistance-phenotyping workflows. This article connects its mechanism and handling properties with LC-MS/MS metabolomics, assay design, and emerging acute necrotizing pancreatitis research.
MDA and Ferroptosis: From Signal to Strategy
2026-08-14
Malondialdehyde is more than an oxidative stress endpoint. This thought-leadership guide explains how MDA measurement can connect ferroptosis biology, sunitinib resistance, and translational assay strategy in clear cell renal cell carcinoma.
Zolmitriptan: From 5-HT1B Signaling to Translation
2026-08-13
A mechanistic and translational guide to using Zolmitriptan as a 5-HT1B receptor agonist, with assay design, product handling, competitive positioning, and a disciplined comparison to TFEB-centered lysosomal research.
Fluoxetine HCl: Reliable Assay Workflows
2026-08-13
Fluoxetine HCl (SKU A2436) can help researchers standardize serotonergic perturbation studies while avoiding common solvent, precipitation, and assay-interpretation errors. This scenario-driven guide connects formulation data with cell viability, proliferation, receptor, neurogenesis, and motivation workflows.
Acetoacetic Acid Sodium Salt in Metabolism Research
2026-08-12
Acetoacetic acid sodium salt, also called sodium 3-oxobutanoate, is a defined ketone-body metabolite for controlled energy metabolism research. Its documented identity, purity, solubility, and storage requirements support reproducible diabetes and fatty acid catabolism experiments when investigators distinguish exogenous substrate exposure from endogenous disease biology.
PKM2 Inhibition: From Metabolism to Translation
2026-08-12
PKM2 inhibitor (compound 3k) offers a research bridge between tumor glycolysis, autophagic cell death, and immunometabolic regulation. This thought-leadership analysis interprets its biochemical, cellular, and xenograft evidence alongside the USP7–PKM2 macrophage study, while defining practical validation steps and the limits of translating preclinical findings into cancer or inflammatory disease programs.
562 records 8/38 page Previous Next First page 上5页 678910 下5页 Last page